Surface Oncology ROA 2017-2020 | SURF

Current and historical return on assets (ROA) values for Surface Oncology (SURF) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Surface Oncology ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-03-31 $-0.03B $0.13B -20.11%
2019-12-31 $-0.06B $0.13B -36.85%
2019-09-30 $-0.02B $0.14B -10.64%
2019-06-30 $-0.02B $0.16B -9.91%
2019-03-31 $-0.02B $0.17B -8.19%
2018-12-31 $-0.01B $0.17B -4.15%
2018-09-30 $-0.05B $0.19B -30.98%
2018-06-30 $-0.04B $0.20B -42.53%
2018-03-31 $-0.03B $0.11B -68.39%
2017-12-31 $-0.05B $0.08B -227.16%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.169B $0.015B
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.204B 33.44
Medtronic (MDT) Ireland $136.933B 22.24
Stryker (SYK) United States $71.285B 27.64
Boston Scientific (BSX) United States $57.170B 33.03
Lonza Group Ag (LZAGY) Switzerland $45.538B 0.00
Baxter (BAX) United States $42.260B 25.85
Terumo (TRUMY) Japan $29.507B 37.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.068B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.693B 23.81
ResMed (RMD) United States $25.439B 36.94
Sunny Optical Technology (SNPTF) China $20.071B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.443B 0.00
Bio-Rad Laboratories (BIO) United States $14.894B 67.36
Insulet (PODD) United States $13.435B 568.47
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.051B 53.24
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.263B 12.46
Hill-Rom Holdings (HRC) United States $6.473B 16.06
Canopy Growth (CGC) Canada $6.398B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.530B 0.00
Neogen (NEOG) United States $4.178B 69.81
Haemonetics (HAE) United States $4.054B 27.02
ICU Medical (ICUI) United States $3.959B 30.20
Envista Holdings (NVST) United States $3.717B 25.35
Abcam (ABCZY) $3.628B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.384B 0.00
National Vision Holdings (EYE) United States $2.857B 444.13
Agios Pharmaceuticals (AGIO) United States $2.785B 0.00
NuVasive (NUVA) United States $2.663B 37.11
TG Therapeutics (TGTX) United States $2.413B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.116B 194.85
AtriCure (ATRC) United States $1.832B 0.00
MacroGenics (MGNX) United States $1.443B 0.00
NanoString Technologies (NSTG) United States $1.418B 0.00
Aphria (APHA) Canada $1.298B 0.00
Cerus (CERS) United States $1.155B 0.00
Aurora Cannabis (ACB) Canada $1.131B 0.00
Cardiovascular Systems (CSII) United States $1.127B 0.00
Owens & Minor (OMI) United States $1.029B 23.06
InMode (INMD) Israel $1.003B 25.31
OraSure Technologies (OSUR) United States $0.987B 0.00
Quanterix (QTRX) United States $0.971B 0.00
Lantheus Holdings (LNTH) United States $0.904B 12.53
PetIQ (PETQ) United States $0.840B 24.26
Phibro Animal Health (PAHC) United States $0.804B 16.02
Meridian Bioscience (VIVO) United States $0.749B 17.30
Omeros (OMER) United States $0.745B 0.00
Vapotherm (VAPO) United States $0.738B 0.00
Surmodics (SRDX) United States $0.644B 70.69
Zynex (ZYXI) United States $0.626B 54.70
VAREX IMAGING (VREX) United States $0.626B 27.12
Eagle Pharmaceuticals (EGRX) United States $0.595B 84.08
BioLife Solutions (BLFS) United States $0.587B 305.50
LeMaitre Vascular (LMAT) United States $0.586B 35.79
Viemed Healthcare (VMD) United States $0.389B 13.90
Cytosorbents (CTSO) United States $0.376B 0.00
HEXO (HEXO) $0.330B 0.00
Utah Medical Products (UTMD) $0.307B 26.30
Neptune Wellness Solutions (NEPT) Canada $0.305B 0.00
InfuSystems Holdings (INFU) United States $0.256B 142.00
Organigram Holdings (OGI) Canada $0.237B 0.00
Female Health (VERU) United States $0.206B 0.00
Exagen (XGN) United States $0.185B 0.00
Chimerix (CMRX) United States $0.182B 0.00
Bovie Medical (APYX) United States $0.179B 0.00
Fonar (FONR) United States $0.170B 15.07
Wound Management Technologies (SMTI) United States $0.148B 0.00
Evolus (EOLS) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.131B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.129B 0.00
Rockwell Medical (RMTI) United States $0.118B 0.00
Chembio Diagnostics (CEMI) United States $0.109B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
MTech Acquisition (KERN) United States $0.085B 0.00
Capricor Therapeutics (CAPR) United States $0.085B 0.00
United-Guardian (UG) United States $0.072B 16.14
Brainsway (BWAY) Israel $0.072B 0.00
Nephros (NEPH) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.052B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.034B 0.00
FSD PHARMA INC (HUGE) Canada $0.025B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Myomo (MYO) United States $0.014B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00